[1]
|
Zeng, Y., Que, T., Lin, J., et al. (2019) Oncogenic ZEB2/miR-637/HMGA1 Signaling Axis Targeting Vimentin Pro-motes the Malignant Phenotype of Glioma. Nucleic Acids, 23, 769-782. https://doi.org/10.1016/j.omtn.2020.12.029
|
[2]
|
Zanders, E.D., Svensson, F. and Bailey, D.S. (2019) Therapy for Glioblastoma: Is It Working? Drug Discovery Today, 24, 1193-1201. https://doi.org/10.1016/j.drudis.2019.03.008
|
[3]
|
陈谦学. 胶质母细胞瘤诊疗研究进展[J]. 肿瘤防治研究, 2022, 49(11): 1103-1106.
|
[4]
|
Diaz, M., Jo, J., Smolkin, M., Ratcliffe, S.J. and Schiff, D. (2021) Risk of Venous Thromboembolism in Grade II-IV Gliomas as a Function of Molecular Subtype. Neurology, 96, e1063-e1069.
https://doi.org/10.1212/WNL.0000000000011414
|
[5]
|
Tabnak, P., Mafakheri, A., Haji Emsailpoor, Z., Kazemi, T. and Shekari, N. (2021) Regulatory Interplay between microRNAs and WNT Pathway in Glioma. Biomedicine & Pharmacotherapy, 143, Article ID: 112187.
https://doi.org/10.1016/j.biopha.2021.112187
|
[6]
|
Aman, A.J., Fulbright, A.N. and Parichy, D.M. (2018) Wnt/β-Catenin Regulates an Ancient Signaling Network during Zebrafish Scale Development. eLife, 7, e37001. https://doi.org/10.7554/eLife.37001
|
[7]
|
Steinhart, Z. and Angers, S. (2018) Wnt Signaling in Development and Tissue Homeostasis. Development, 145, dev146589. https://doi.org/10.1242/dev.146589
|
[8]
|
Nusse, R. and Clevers, H. (2017) Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities. Cell, 169, 985-999. https://doi.org/10.1016/j.cell.2017.05.016
|
[9]
|
Clevers, H. and Nusse, R. (2012) Wnt/β-Catenin Signaling and Disease. Cell, 149, 1192-1205.
https://doi.org/10.1016/j.cell.2012.05.012
|
[10]
|
Zhang, J., Cai, H., Sun, L., Zhan, P., Chen, M., Zhang, F., Ran, Y. and Wan, J. (2018) LGR5, a Novel Functional Glioma Stem Cell Marker, Promotes EMT by Activating the Wnt/β-Catenin Pathway and Predicts Poor Survival of Glioma Patients. Journal of Experimental & Clinical Cancer Research, 37, Article No. 225.
https://doi.org/10.1186/s13046-018-0864-6
|
[11]
|
Hayat, R., Manzoor, M. and Hussain, A. (2022) Wnt Signaling Pathway: A Comprehensive Review. Cell Biology International, 46, 863-877. https://doi.org/10.1002/cbin.11797
|
[12]
|
Sheng, J., He, X., Yu, W., Chen, Y., Long, Y., Wang, K., Zhu, S. and Liu, Q. (2021) P53-Targeted lncRNA ST7-AS1 Acts as a Tumour Suppressor by Interacting with PTBP1 to Suppress the Wnt/β-Catenin Signalling Pathway in Glioma. Cancer Letters, 503, 54-68. https://doi.org/10.1016/j.canlet.2020.12.039
|
[13]
|
Wang, Z., Li, Z. and Ji, H. (2021) Direct Targeting of β-Catenin in the Wnt Signaling Pathway: Current Progress and Perspectives. Medicinal Research Reviews, 41, 2109-2129. https://doi.org/10.1002/med.21787
|
[14]
|
Liu, K., Jiang, L., Shi, Y., Liu, B., He, Y., Shen, Q., Jiang, X., Nie, Z., Pu, J., Yang, C. and Chen, Y. (2022) Hypoxia-Induced GLT8D1 Promotes Glioma Stem Cell Maintenance by Inhibiting CD133 Degradation through N-Linked Glycosylation. Cell Death & Differentiation, 29, 1834-1849. https://doi.org/10.1038/s41418-022-00969-2
|
[15]
|
Davidson, G. (2021) LRPs in WNT Signalling. In: Schulte, G. and Kozielewicz, P., Eds., Pharmacology of the WNT Signaling System. Handbook of Experimental Pharmacology, Vol. 269, Springer, Cham, 45-73.
https://doi.org/10.1007/164_2021_526
|
[16]
|
Jones, T.S. and Holland, E.C. (2012) Standard of Care Therapy for Malignant Glioma and Its Effect on Tumor and Stromal Cells. Oncogene, 31, 1995-2006. https://doi.org/10.1038/onc.2011.398
|
[17]
|
Zhou, C., Zhang, Y., Dai, J., Zhou, M., Liu, M., Wang, Y., Chen, X.-Z. and Tang, J. (2016) Pygo2 Functions as a Prognostic Factor for Glioma due to Its up-Regulation of H3K4me3 and Promotion of MLL1/MLL2 Complex Recruitment. Scientific Reports, 6, Article No. 22066. https://doi.org/10.1038/srep22066
|
[18]
|
Kaur, N., Chettiar, S., Rathod, S., Rath, P., Muzumdar, D., Shaikh, M.L. and Shiras, A. (2013) Wnt3a Mediated Activation of Wnt/β-Catenin Signaling Promotes Tumor Progression in Glioblastoma. Molecular and Cellular Neuroscience, 54, 44-57. https://doi.org/10.1016/j.mcn.2013.01.001
|
[19]
|
Wu, W., Tian, Y., Wan, H., Song, Y., Li, J. and Zhang, L. (2013) The Expressions of Wnt/β-Catenin Pathway-Related Components in Brainstem Gliomas. Canadian Journal of Neuro-logical Sciences, 40, 355-360.
https://doi.org/10.1017/S031716710001430X
|
[20]
|
Denysenko, T., Annovazzi, L., Cassoni, P., Melcarne, A., Mellai, M. and Schiffer, D. (2016) WNT/β-Catenin Signaling Pathway and Downstream Modulators in Low- and High-Grade Glioma. Cancer Genomics & Proteomics, 13, 31-45.
|
[21]
|
杨烽. 脑胶质瘤信号通路的研究进展(综述) [J]. 安徽医专学报, 2022, 21(4): 77-79+82.
|
[22]
|
陈静, 董善武, 陈咏丽, 陈海珊, 蒋姝, 陈澄, 罗超. miR-640通过抑制SLIT1介导Wnt/β-catenin通路促进脑胶质瘤对替莫唑胺的耐药[J]. 肿瘤学杂志, 2022, 28(7): 568-573.
|